Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Beth Israel Med. Ctr., ACTU, New York

Weill Cornell Chelsea CRS, New York

NY Univ. HIV/AIDS CRS, New York

Weill Cornell Uptown CRS, New York

Trillium Health ACTG CRS, Rochester

McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit, Rochester

Univ. of Rochester ACTG CRS, Rochester

University of Pittsburgh CRS, Pittsburgh

Univ. of Pennsylvania Health System, Presbyterian Med. Ctr., Philadelphia

Georgetown University CRS (GU CRS), Washington D.C.

Johns Hopkins University CRS, Baltimore

Chapel Hill CRS, Chapel Hill

Vanderbilt Therapeutics (VT) CRS, Nashville

MetroHealth CRS, Cleveland

Northwestern University CRS, Chicago

University of Colorado Hospital CRS, Aurora

UCLA CARE Center CRS, Los Angeles

UCSD Antiviral Research Center CRS, San Diego

Ucsf Hiv/Aids Crs, San Francisco

Santa Clara Valley Med. Ctr., San Jose

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

Alabama Therapeutics CRS, Birmingham

University of Southern California CRS, Los Angeles

Stanford AIDS Clinical Trials Unit CRS, Palo Alto

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Massachusetts General Hospital CRS (MGH CRS), Boston

Brigham and Women's Hosp. ACTG CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Washington University Therapeutics (WT) CRS, St Louis

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha

Columbia P&S CRS, New York

Cincinnati CRS, Cincinnati

The Miriam Hospital Clinical Research Site (TMH CRS) CRS, Providence

Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic, Dallas

Univ. of Texas Medical Branch, ACTU, Galveston

Puerto Rico AIDS Clinical Trials Unit CRS, San Juan